This company has shut down. Klivo is no longer operating — its last tracked round was a Series A in 2022.
Explore the Startup GraveyardKlivo offers treatments for chronic diseases.
Klivo has raised $8.8M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Klivo's investors include Norte Ventures, Canary, Civilization Ventures, Tau Ventures, Valor Capital Group.
Klivo is headquartered in São Paulo, Brazil.
Klivo offers treatments for chronic diseases.
Klivo is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Klivo — Funding & Investors." VCBacked, March 7, 2022, https://www.vcbacked.co/company/klivo. Accessed July 23, 2026.
VCBacked. (2022). Klivo — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/klivo
{{cite web |title=Klivo — Funding & Investors |url=https://www.vcbacked.co/company/klivo |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated